Verastem, Inc. (VSTM)
4.24
-0.03
(-0.70%)
USD |
NASDAQ |
May 22, 16:00
4.24
0.00 (0.00%)
After-Hours: 20:00
Verastem EPS Diluted (Quarterly) : -0.3723 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Altimmune, Inc. | -0.1813 |
| Ocugen, Inc. | -0.0586 |
| BioXcel Therapeutics, Inc. | -0.5384 |
| Xilio Therapeutics, Inc. | -0.5829 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.59M |
| Revenue (Quarterly) | 18.67M |
| Total Expenses (Quarterly) | 55.26M |
| Enterprise Value | 276.38M |
| Gross Profit Margin (Quarterly) | 83.66% |
| Profit Margin (Quarterly) | -196.0% |
| Earnings Yield | -64.58% |
| Normalized Earnings Yield | -58.03 |